Penwest Pharmaceuticals is selling itself too cheaply to Endo Pharmaceuticals and West Acquisition Corp., for $168 million or $5 a share, shareholders say in a class action in Putnam County Court, N.Y.
Categories /
Uncategorized
Subscribe to our free newsletters
Our weekly newsletter Closing Arguments offers the latest about ongoing trials, major litigation and rulings in courthouses around the U.S. and the world, while the monthly Under the Lights dishes the legal dirt from Hollywood, sports, Big Tech and the arts.

